{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-049426","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2026-07-23T20:51:27+00:00","discovered_at":"2026-07-23T20:52:18.383585+00:00","generated_at":"2026-07-23T20:52:23.440312+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Serina Therapeutics amends CEO Steve Ledger's employment agreement with enhanced severance and equity acceleration","bullets":["Base salary of $500,000 unchanged; target annual bonus set at 50% of base salary.","Non-CIC termination severance: 12 months base salary plus pro-rated target bonus, 12 months COBRA.","CIC termination severance: 1.5x base salary plus 1.5x target bonus plus pro-rated bonus, 18 months COBRA.","Full acceleration of unvested time-based equity awards upon a Qualifying CIC Termination.","Non-compete covenant for 2 years; non-solicit and no-hire for 18 months post-termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-049426","json":"https://secwatch.observer/filing/0001628280-26-049426.json","markdown":"https://secwatch.observer/filing/0001628280-26-049426.md","text":"https://secwatch.observer/filing/0001628280-26-049426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/0001628280-26-049426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000162828026049426/ser-20260719.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T20:52:23.440312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}